Drexel Morgan & Co. Johnson & Johnson Transaction History

Drexel Morgan & Co.

$538 Million
Q3 2024

A detailed history of Drexel Morgan & Co. transactions in Johnson & Johnson stock. As of the latest transaction made, Drexel Morgan & Co. holds 216,257 shares of JNJ stock, worth $31.7 Million. This represents 6.51% of its overall portfolio holdings.

Number of Shares

216,257

Previous 216,257 -0.0%

Holding current value

$31.7 Million

Previous $31.6 Million 10.88%

% of portfolio

6.51%

Previous 6.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$155.22 - $162.74 $24,835 - $26,038	160 Added 0.07%	216,257 $34.2 Million
Q4 2023 Feb 08, 2024	BUY	$145.6 - $158.88 $14,560 - $15,888	100 Added 0.05%	216,097 $33.9 Million
Q3 2023 Nov 08, 2023	BUY	$155.75 - $174.48 $46,725 - $52,344	300 Added 0.14%	215,997 $33.6 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $42,429 - $47,213	263 Added 0.12%	215,697 $35.2 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $283,109 - $314,610	-1,753 Reduced 0.81%	215,434 $34.8 Million
Q2 2021 Aug 12, 2021	SELL	$159.48 - $171.07 $469,030 - $503,116	-2,941 Reduced 1.34%	217,187 $35.8 Million
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $13.7 Million - $15.7 Million	100,000 Added 83.24%	220,128 $34.6 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $40,710 - $44,610	290 Added 0.24%	120,128 $17.9 Million
Q2 2020 Aug 11, 2020	BUY	$128.81 - $155.51 $31,558 - $38,099	245 Added 0.2%	119,838 $16.9 Million
Q1 2020 May 08, 2020	BUY	$111.14 - $153.99 $11 Million - $15.2 Million	98,675 Added 471.72%	119,593 $15.7 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $162,690 - $186,857	1,276 Added 6.5%	20,918 $3.05 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $47,225 - $52,876	-372 Reduced 1.86%	19,642 $2.54 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $9,573 - $10,529	73 Added 0.37%	20,014 $2.79 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $30,801 - $34,248	245 Added 1.24%	19,941 $2.79 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $45,327 - $54,552	369 Added 1.91%	19,696 $2.54 Million
Q3 2018 Nov 09, 2018	BUY	$121.58 - $142.88 $19,331 - $22,717	159 Added 0.83%	19,327 $2.67 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $103,400 - $114,104	866 Added 4.73%	19,168 $2.33 Million
Q1 2018 May 10, 2018	BUY	$125.1 - $148.14 $12,259 - $14,517	98 Added 0.54%	18,302 $2.35 Million
Q4 2017 Feb 12, 2018	SELL	$131.22 - $143.62 $11,284 - $12,351	-86 Reduced 0.47%	18,204 $2.54 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $28,094 - $29,377	-217 Reduced 1.17%	18,290 $2.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	18,507	18,507 $2.45 Million

Others Institutions Holding JNJ

# of Institutions

4,276

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Drexel Morgan & Co., based on Form 13F filings with the SEC.

News

Stay updated on Drexel Morgan & Co. with notifications on news.

Account